Source: http://brainblogger.com/2016/09/23/best-and-worst-in-health-and-healthcare-july-august-2016/
The northern hemisphere’s summer is ending and that is definitely bad news. The good news is that this was not a silly season in health and healthcare research.
Here’s the best and worst news of the summer.
The best
Drug repurposing screening reveals possible candidates for anti-Zika therapy
Developing a new drug is a long process, but the Zika virus outbreak has created a global health emergency and a pressing need for therapies that is incompatible with the timings of drug development. This led to a major study published in Nature Medicine in which over 6,000 compounds were screened for possible drug repurposing, including approved drugs, clinical trial drug candidates and pharmacologically active compounds. This screening allowed the identification of compounds that were able to inhibit Zika infection, suppress the effects of infection in neurons, or inhibit viral replication. Furthermore, combination trea…
Source: http://brainblogger.com/2016/09/23/best-and-worst-in-health-and-healthcare-july-august-2016/
The northern hemisphere’s summer is ending and that is definitely bad news. The good news is that this was not a silly season in health and healthcare research.
Here’s the best and worst news of the summer.
The best
Drug repurposing screening reveals possible candidates for anti-Zika therapy
Developing a new drug is a long process, but the Zika virus outbreak has created a global health emergency and a pressing need for therapies that is incompatible with the timings of drug development. This led to a major study published in Nature Medicine in which over 6,000 compounds were screened for possible drug repurposing, including approved drugs, clinical trial drug candidates and pharmacologically active compounds. This screening allowed the identification of compounds that were able to inhibit Zika infection, suppress the effects of infection in neurons, or inhibit viral replication. Furthermore, combination trea…
What Do You Think?
comments